$CURR news alert: June 16, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created position of Chief Business Officer. Mr. Berlent will be responsible for corporate strategy, sourcing and executing business development opportunities and will serve as a member of the company’s Executive Management Committee. He will report to Rob Davidson, CURE Pharmaceutical’s Chief Executive Officer.